1
|
Olsson AK, Dimberg A, Kreuger J and
Claesson-Welsh L: VEGF receptor signaling - in control of vascular
function. Nat Rev Mol Cell Biol. 7:359–371. 2006. View Article : Google Scholar : PubMed/NCBI
|
2
|
Podar K and Anderson KC: The
pathophysiologic role of VEGF in hematologic malignancies:
therapeutic implications. Blood. 105:1383–1395. 2005. View Article : Google Scholar : PubMed/NCBI
|
3
|
Mayerhofer M, Valent P, Sperr WR, Griffin
JD and Sillaber C: BCR/ABL induces expression of vascular
endothelial growth factor and its transcriptional activator,
hypoxia inducible factor-1alpha, through a pathway involving
phosphoinositide 3-kinase and the mammalian target of rapamycin.
Blood. 100:3767–3775. 2002. View Article : Google Scholar
|
4
|
Perez-Atayde AR, Sallan SE, Tedrow U,
Connors S, Allred E and Folkman J: Spectrum of tumor angiogenesis
in the bone marrow of children with acute lymphoblastic leukemia.
Am J Pathol. 150:815–821. 1997.PubMed/NCBI
|
5
|
Ghosh AK, Shanafelt TD, Cimmino A, et al:
Aberrant regulation of pVHL levels by microRNA promotes the
HIF/VEGF axis in CLL B cells. Blood. 113:5568–5574. 2009.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Jiang GS, Yang WH, Wen PE, Ren X, Tang TH
and Ren HQ: HIF-1α independent down-regulation of VEGF expression
in HL60 cells after in vitro exposure to ATRA. Blood.
110:42902007.
|
7
|
Lidgren A, Hedberg Y, Grankvist K, Torgny
R, Vasko J and Ljungberg B: The expression of hypoxia-inducible
factor 1alpha is a favorable independent prognostic factor in renal
cell carcinoma. Clin Cancer Res. 11:1129–1135. 2005.PubMed/NCBI
|
8
|
Schuch G, Machluf M, Bartsch G Jr, et al:
In vivo administration of vascular endothelial growth factor (VEGF)
and its antagonist, soluble neuropilin-1, predicts a role of VEGF
in the progression of acute myeloid leukemia in vivo. Blood.
100:4622–4628. 2002. View Article : Google Scholar : PubMed/NCBI
|
9
|
Ter Elst A, Ma B, Scherpen FJ, et al:
Repression of vascular endothelial growth factor expression by the
runt-related transcription factor 1 in acute myeloid leukemia.
Cancer Res. 71:2761–2771. 2011.PubMed/NCBI
|
10
|
Weidenaar AC, ter Elst A, Koopmans-Klein
G, et al: High acute myeloid leukemia derived VEGFA levels are
associated with a specific vascular morphology in the leukemic bone
marrow. Cell Oncol. 34:289–296. 2011. View Article : Google Scholar : PubMed/NCBI
|
11
|
Bajpai J, Sharma A, Kumar L, et al: Acute
promyelocytic leukemia: an experience from a tertiary care centre
in north India. Indian J Cancer. 48:316–322. 2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Tee MK, Vigne JL and Taylor RN: All-trans
retinoic acid inhibits vascular endothelial growth factor
expression in a cell model of neutrophil activation. Endocrinology.
147:1264–1270. 2006. View Article : Google Scholar : PubMed/NCBI
|
13
|
Wang ES, Teruya-Feldstein J, Wu Y, Zhu Z,
Hicklin DJ and Moore MA: Targeting autocrine and paracrine VEGF
receptor pathways inhibits human lymphoma xenografts in vivo.
Blood. 104:2893–2902. 2004. View Article : Google Scholar : PubMed/NCBI
|
14
|
Vaupel P: The role of hypoxia-induced
factors in tumor progression. Oncologist. 9(Suppl 5): 10–17. 2004.
View Article : Google Scholar
|
15
|
Ohno H, Shirato K, Sakurai T, et al:
Effect of exercise on HIF-1 and VEGF signaling. J Phys Fitness
Sports Med. 1:5–16. 2012. View Article : Google Scholar
|
16
|
Loeffler S, Fayard B, Weis J and
Weissenberger J: Interleukin-6 induces transcriptional activation
of vascular endothelial growth factor (VEGF) in astrocytes in vivo
and regulates VEGF promoter activity in glioblastoma cells via
direct interaction between STAT3 and Sp1. Int J Cancer.
115:202–213. 2005. View Article : Google Scholar
|
17
|
Xie K, Wei D, Shi Q and Huang S:
Constitutive and inducible expression and regulation of vascular
endothelial growth factor. Cytokine Growth Factor Rev. 15:297–324.
2004. View Article : Google Scholar : PubMed/NCBI
|
18
|
Colla S, Tagliaferri S, Morandi F, et al:
The new tumor-suppressor gene inhibitor of growth family member 4
(ING4) regulates the production of proangiogenic molecules by
myeloma cells and suppresses hypoxia-inducible factor-1 alpha
(HIF-1alpha) activity: involvement in myeloma-induced angiogenesis.
Blood. 110:4464–4475. 2007. View Article : Google Scholar
|
19
|
Lee CC, Chen SC, Tsai SC, et al:
Hyperbaric oxygen induces VEGF expression through ERK, JNK and
c-Jun/AP-1 activation in human umbilical vein endothelial cells. J
Biomed Sci. 13:143–156. 2006. View Article : Google Scholar : PubMed/NCBI
|
20
|
Mizukami Y, Fujiki K, Duerr EM, et al:
Hypoxic regulation of vascular endothelial growth factor through
the induction of phosphatidylinositol 3-kinase/Rho/ROCK and c-Myc.
J Biol Chem. 281:13957–13963. 2006. View Article : Google Scholar : PubMed/NCBI
|
21
|
Dadiani M, Seger D, Kreizman T, et al:
Estrogen regulation of vascular endothelial growth factor in breast
cancer in vitro and in vivo: the role of estrogen receptor alpha
and c-Myc. Endocr Relat Cancer. 16:819–834. 2009. View Article : Google Scholar : PubMed/NCBI
|
22
|
Yang Y, Hu Y, Wang Y, Li J, Liu F and
Huang L: Nanoparticle delivery of pooled siRNA for effective
treatment of non-small cell lung cancer. Mol Pharm. Jun
22–2012.(Epub ahead of print).
|